Chemoimmunotherapy of small cell bronchogenic carcinoma
Authors:
Open Access
Abstract
Thirty‐one patients with small cell bronchogenic carcinoma were treated with a regimen of cyclophosphamide, Adriamycin and vincristine. Radiotherapy was given to patients with limited disease. Nonspecific immunotherapy consisting of BCG scarification was administered after each chemotherapy course. The results of treatment for this group were compared with those for a group of 45 patients treated similarly but with no immunotherapy. Therapeutic results, expressed in length of survival and rate of response, were similar. Myelosuppression was not modified by the addition of BCG scarification. This study showed no benefit from the use of such nonspecific immunotherapy.Keywords
This publication has 7 references indexed in Scilit:
- Survival with inoperable lung cancer.An integration of prognostic variables based on simple clinical criteriaCancer, 1977
- The cardiotoxicity of adriamycin and daunomycin in childrenCancer, 1976
- Combination chemotherapy in oat cell carcinoma of the lungCancer, 1975
- Cyclophosphamide, Vincristine and Sequential Split-Course Radiotherapy in the Treatment of Small Cell Lung CancerChest, 1975
- Small cell carcinoma of the lung: Staging, paraneoplastic syndromes, treatment, and survivalCancer, 1974
- The Survival of Patients with Inoperable Lung Cancer: A Large-Scale Randomized Study of Radiation Therapy Versus PlaceboRadiology, 1968
- Bronchogenic CarcinomaArchives of Surgery, 1967